| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | -100.0% |
| R&D Expense | $34.4M | +13.6% |
| SG&A Expense | $14.6M | +4.4% |
| Operating Income | -$49.0M | -14.1% |
| Pre-tax Income | $13.3M | — |
| Income Tax | $0 | — |
| Net Income | $13.3M | +138.9% |
| EPS (Basic) | $0.22 | +106.0% |
| EPS (Diluted) | -$0.79 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $10.5M | +18.0% |
| Short-term Investments | $86.1M | +625.7% |
| Current Assets | $101.1M | +324.7% |
| Total Assets | $172.8M | +291.0% |
| Current Liabilities | $10.7M | +33.9% |
| Total Liabilities | $21.3M | +17.0% |
| Stockholders' Equity | $151.5M | +483.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$44.8M | -30.6% |
| Capital Expenditures | $933K | +176.7% |
| Investing Cash Flow | -$121.7M | -917.4% |
| Financing Cash Flow | $168.3M | — |
| Free Cash Flow | -$45.7M | -32.0% |
| +78.5% |